| |
| |
|
| Insider
Information: |
Trizzino John |
| Relationship: |
President and COO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,972 |
|
|
| Total
Value |
$10,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President and COO |
2024-03-10 |
27,972 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, CMO and CBO |
• – – |
2021-01-05 |
4 |
AS |
$110.25 |
$1,949,522 |
D/D |
(17,407) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CMO and CBO |
• – – |
2021-01-07 |
4 |
AS |
$124.17 |
$62,830 |
D/D |
(506) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
D |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-01-25 |
4/A |
AS |
$128.60 |
$9,388 |
D/D |
(73) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
AS |
$282.00 |
$877,766 |
D/D |
(3,022) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-09 |
4 |
AS |
$324.50 |
$62,953 |
D/D |
(194) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
AS |
$150.31 |
$493,824 |
D/D |
(3,021) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-09 |
4 |
AS |
$168.09 |
$31,937 |
D/D |
(190) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
AS |
$190.10 |
$574,292 |
D/D |
(3,021) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-07 |
4 |
AS |
$178.03 |
$34,004 |
D/D |
(191) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
AS |
$163.03 |
$560,471 |
D/D |
(3,022) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-07 |
4 |
AS |
$176.60 |
$33,559 |
D/D |
(190) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
D |
$174.84 |
$31,296 |
D/D |
(179) |
477 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
D |
$171.74 |
$30,913 |
D/D |
(180) |
477 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
D |
$177.29 |
$31,735 |
D/D |
(179) |
478 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
D |
$290.18 |
$52,813 |
D/D |
(182) |
481 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
D |
$174.84 |
$2,448 |
D/D |
(14) |
656 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
D |
$177.29 |
$2,305 |
D/D |
(13) |
657 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
D |
$171.74 |
$2,404 |
D/D |
(14) |
657 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
D |
$290.18 |
$2,321 |
D/D |
(8) |
663 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-03-05 |
4 |
OE |
$5.95 |
$50,148 |
D/D |
3,404 |
670 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-04-05 |
4 |
OE |
$5.95 |
$115,771 |
D/D |
3,404 |
670 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, Chief Commercial Officer |
• – – |
2021-02-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-05 |
4 |
OE |
$5.95 |
$50,160 |
D/D |
3,406 |
671 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-06-25 |
4 |
D |
$189.79 |
$76,485 |
D/D |
(403) |
718 |
0 |
- |
|
91 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
